Status:
RECRUITING
Effects of Telemonitoring in Quality of Life Amongst Cancer Patients
Lead Sponsor:
Universidad Nacional Andres Bello
Collaborating Sponsors:
Centro para la Prevención y Control del Cáncer (CECAN), Santiago, Chile
Conditions:
Cancer
Telemonitoring
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This interventional study aims to explore the potential of a smartphone app, Contigo, in enhancing the quality of life for patients with various cancers compared to standard care. The investigators wi...
Detailed Description
The primary objective of this study is to determine if utilizing a smartphone app for disease monitoring improves the self-reported quality of life using validated questionnaires in patients with dive...
Eligibility Criteria
Inclusion
- Adult patients (\>18 years old).
- Recent histologically confirmed diagnosis (within the last 3 months) of bronchogenic, breast, gallbladder, gastric, colorectal, or prostate cancer in any of its forms.
- Awaiting initiation of curative intent treatment for the disease using any modality (radiation therapy, chemotherapy, immunotherapy, etc.) at the UC-Christus Cancer Center.
- Possession of a smartphone, regardless of its native operating system (iOS® or Android®).
- Willingness to sign an informed consent form to participate in the study.
Exclusion
- Any form of sensory impairment preventing app usage.
- Cognitive impairment.
- Psychiatric pathology hindering app usage.
- Unwillingness to participate in the study.
- Concurrent participation in another clinical trial addressing healthcare technologies.
Key Trial Info
Start Date :
April 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06086990
Start Date
April 1 2024
End Date
March 1 2025
Last Update
April 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Christus Cancer Centre
Santiago, Chile